Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Practice Guidelines as Topic | 3 | 2020 | 261 | 1.120 |
Why?
|
| Family Practice | 3 | 2014 | 15 | 0.930 |
Why?
|
| Medical Overuse | 1 | 2020 | 7 | 0.690 |
Why?
|
| Quality Improvement | 1 | 2020 | 140 | 0.620 |
Why?
|
| Overweight | 2 | 2009 | 72 | 0.600 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 110 | 0.580 |
Why?
|
| Glioblastoma | 1 | 2017 | 13 | 0.560 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 42 | 0.550 |
Why?
|
| Rat-Bite Fever | 1 | 2017 | 1 | 0.550 |
Why?
|
| Purpura | 1 | 2017 | 2 | 0.550 |
Why?
|
| Fever | 1 | 2017 | 34 | 0.540 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2016 | 3 | 0.530 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 93 | 0.520 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 111 | 0.510 |
Why?
|
| Child Development | 2 | 2015 | 69 | 0.510 |
Why?
|
| Sepsis | 1 | 2017 | 115 | 0.500 |
Why?
|
| Humans | 20 | 2020 | 27309 | 0.500 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2015 | 4 | 0.500 |
Why?
|
| Thromboembolism | 1 | 2015 | 18 | 0.490 |
Why?
|
| Arthralgia | 1 | 2017 | 135 | 0.490 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 37 | 0.480 |
Why?
|
| Plagiocephaly | 1 | 2015 | 1 | 0.470 |
Why?
|
| Craniosynostoses | 1 | 2015 | 2 | 0.470 |
Why?
|
| Head Protective Devices | 1 | 2015 | 2 | 0.470 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 17 | 0.470 |
Why?
|
| Fasting | 1 | 2015 | 21 | 0.470 |
Why?
|
| Hypertension | 1 | 2016 | 194 | 0.460 |
Why?
|
| Anticoagulants | 1 | 2015 | 88 | 0.460 |
Why?
|
| Skull | 1 | 2015 | 21 | 0.460 |
Why?
|
| Lipids | 1 | 2015 | 50 | 0.450 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 380 | 0.450 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 48 | 0.450 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 74 | 0.450 |
Why?
|
| Nicotinic Agonists | 1 | 2014 | 3 | 0.440 |
Why?
|
| Penicillins | 1 | 2014 | 9 | 0.430 |
Why?
|
| Intergenerational Relations | 1 | 2014 | 7 | 0.430 |
Why?
|
| Physicians, Family | 1 | 2014 | 4 | 0.430 |
Why?
|
| Cellulitis | 1 | 2014 | 10 | 0.430 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 117 | 0.430 |
Why?
|
| Gonorrhea | 1 | 2013 | 7 | 0.430 |
Why?
|
| Chlamydia Infections | 1 | 2013 | 7 | 0.430 |
Why?
|
| Smoking Cessation | 1 | 2014 | 46 | 0.420 |
Why?
|
| Specimen Handling | 1 | 2013 | 44 | 0.420 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 146 | 0.420 |
Why?
|
| Teaching | 1 | 2013 | 51 | 0.410 |
Why?
|
| Mass Media | 1 | 2013 | 10 | 0.410 |
Why?
|
| Faculty, Medical | 1 | 2013 | 44 | 0.400 |
Why?
|
| Smoking | 1 | 2014 | 183 | 0.400 |
Why?
|
| Publishing | 1 | 2013 | 34 | 0.390 |
Why?
|
| Menorrhagia | 1 | 2011 | 2 | 0.370 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 291 | 0.360 |
Why?
|
| Menstruation | 1 | 2011 | 5 | 0.360 |
Why?
|
| Antifibrinolytic Agents | 1 | 2011 | 17 | 0.350 |
Why?
|
| Evidence-Based Medicine | 2 | 2009 | 164 | 0.350 |
Why?
|
| Tranexamic Acid | 1 | 2011 | 17 | 0.350 |
Why?
|
| Female | 10 | 2017 | 15334 | 0.350 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 324 | 0.340 |
Why?
|
| Bottle Feeding | 1 | 2009 | 14 | 0.320 |
Why?
|
| Birth Weight | 1 | 2009 | 38 | 0.320 |
Why?
|
| Congenital Hypothyroidism | 1 | 2008 | 2 | 0.290 |
Why?
|
| Thyrotropin | 1 | 2008 | 49 | 0.280 |
Why?
|
| Male | 8 | 2016 | 14887 | 0.270 |
Why?
|
| Tuberculin | 1 | 2006 | 1 | 0.260 |
Why?
|
| BCG Vaccine | 1 | 2006 | 2 | 0.260 |
Why?
|
| Tuberculosis | 1 | 2006 | 19 | 0.260 |
Why?
|
| Middle Aged | 3 | 2017 | 9068 | 0.150 |
Why?
|
| Risk Factors | 3 | 2009 | 2335 | 0.150 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2017 | 2 | 0.140 |
Why?
|
| Ceftriaxone | 1 | 2017 | 4 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 36 | 0.130 |
Why?
|
| Risk | 1 | 2017 | 205 | 0.130 |
Why?
|
| Dyspnea | 1 | 2017 | 43 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2009 | 562 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 126 | 0.130 |
Why?
|
| Adult | 3 | 2016 | 7946 | 0.120 |
Why?
|
| Rats | 1 | 2017 | 660 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2016 | 196 | 0.120 |
Why?
|
| Child | 2 | 2009 | 1269 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 1807 | 0.120 |
Why?
|
| Pregnancy | 1 | 2015 | 339 | 0.110 |
Why?
|
| Maternal Welfare | 1 | 2009 | 2 | 0.080 |
Why?
|
| Infant Formula | 1 | 2009 | 18 | 0.080 |
Why?
|
| Animals | 1 | 2017 | 3682 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 305 | 0.070 |
Why?
|
| Sex Factors | 1 | 2009 | 469 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 185 | 0.070 |
Why?
|
| Infant | 1 | 2009 | 517 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2009 | 624 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 4841 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2008 | 69 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 350 | 0.070 |
Why?
|
| Age Factors | 1 | 2009 | 779 | 0.070 |
Why?
|
| Immunization, Secondary | 1 | 2006 | 4 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2009 | 462 | 0.070 |
Why?
|
| Tuberculin Test | 1 | 2006 | 9 | 0.070 |
Why?
|
| Mass Screening | 1 | 2008 | 174 | 0.060 |
Why?
|
| Obesity | 1 | 2009 | 309 | 0.060 |
Why?
|
| Time Factors | 1 | 2009 | 1444 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 486 | 0.060 |
Why?
|
| Adolescent | 1 | 2009 | 2185 | 0.050 |
Why?
|
| Aged | 1 | 2016 | 9119 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2006 | 1903 | 0.040 |
Why?
|